Avadel Pharmaceuticals (AVDL) Total Liabilities: 2013-2021
Historic Total Liabilities for Avadel Pharmaceuticals (AVDL) over the last 9 years, with Dec 2021 value amounting to $169.0 million.
- Avadel Pharmaceuticals' Total Liabilities fell 4.20% to $158.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $158.2 million, marking a year-over-year decrease of 4.20%. This contributed to the annual value of $169.0 million for FY2021, which is 13.16% up from last year.
- As of FY2021, Avadel Pharmaceuticals' Total Liabilities stood at $169.0 million, which was up 13.16% from $149.4 million recorded in FY2020.
- Over the past 5 years, Avadel Pharmaceuticals' Total Liabilities peaked at $187.5 million during FY2018, and registered a low of $149.4 million during FY2020.
- In the last 3 years, Avadel Pharmaceuticals' Total Liabilities had a median value of $169.0 million in 2021 and averaged $166.3 million.
- Per our database at Business Quant, Avadel Pharmaceuticals' Total Liabilities dropped by 17.56% in 2017 and then increased by 13.16% in 2021.
- Yearly analysis of 5 years shows Avadel Pharmaceuticals' Total Liabilities stood at $167.7 million in 2017, then climbed by 11.82% to $187.5 million in 2018, then fell by 3.67% to $180.6 million in 2019, then fell by 17.31% to $149.4 million in 2020, then increased by 13.16% to $169.0 million in 2021.